New York, United States, April 22, 2025 -- SleepHapp Medical, a provider of sleep apnea treatment solutions, has added the ...

Investors looking for exposure to the growing field of respiratory healthcare and sleep apnoea treatment may find themselves comparing two ASX-listed giants: Fisher & Paykel Healthcare Corporation ...

Fisher & Paykel Healthcare, Glidewell, Inspire Medical Systems, Koninklijke Philips, Natus Medical, Nihon Kohden Corporation, ResMed, SomnoMed, and ZOLL Medical, each offering a range of devices ...

Fisher & Paykel ... that sets Fisher & Paykel apart in the selection of continuous or variable positive airway pressure machines and masks for treatment of obstructive sleep apnea, or OSA.

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will be a tailwind.

What is the current share price of Fisher & Paykel Healthcare Corporation Limited (FPH)? Fisher & Paykel Healthcare Corporation Limited's (FPH) current share price is $31.43. This constitutes a price ...

Fisher & Paykel Healthcare Corporation Limited ... and the treatment of obstructive sleep apnea. Their products are distributed in over 120 countries globally. YTD Price Performance:-36.90% ...

Designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea.